Hi, what are you looking for?
Jewish Business News
Search results for "Perrigo "
Business
Both Perrigo and Teva are down on the Tel Aviv Stock Exchange following the Independence Day break. After US-Israeli pharmaceuticals company Perrigo (PRGO) rejected...
Business
Generic drugmaker Mylan (MYL) said on Friday it would take its $31 billion offer for Perrigo Co Plc directly to shareholders, in what is...
World News
The rejection assists Teva's $41 billion bid for Mylan, which is contingent on the Perrigo deal not going ahead.
Business
Kenalog® Spray annual sales were approximately $16 million according to IMS Health.
Business
Israel’s Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver...
Business
Bloomberg reports that increased competition with cheaper generics may push Teva to make a major acquisition soon. Perrigo Company (NYSE:PRGO; TASE:PRGO) may be a...
IPOs
– The company will use the offering to help finance the $4.5 billion acquisition of Omega Pharma. OTC pharmaceutical company Perrigo Company (NYSE:PRGO; TASE:PRGO)...
Business
– Perrigo is expanding its reach into Europe through a $3.1 billion acquisition of one of the continent’s biggest suppliers of non-prescription medicines....
Business
– The generic drug company’s fourth quarter results beat analysts’ estimates. Perrigo Company (NYSE:PRGO; TASE:PRGO) released its fourth quarter and full year results today....